Bull
$5.75
Scenario price
$1.250
+0.133 (+10.62%)At close
American Vanguard Corporation is a diversified specialty and agriculture products company, which develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. It conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses. It synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection. These products, which include insecticides, fungicides, and biorationals, are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories.
American Vanguard Corp is not a good buy right now due to its declining performance and negative financial indicators. The current price is $1.60, which is down 58.01% year-to-date. The RSI is extremely low at 4.661, indicating oversold conditions, but this may not be a strong enough signal for a recovery. Additionally, the forward P/E ratio is 15.083, which is relatively high given the company's recent performance. The main risk is the significant decline in net income, which has been negative for multiple quarters, with the latest quarter showing a net income of -9,868,000 USD. Overall, the financial health and market sentiment do not favor a buy at this time.
Lake Street
$12
2025-06-09
Lake Street
2025-06-09
Price Target
$12
Lake Street
$14
2024-07-22
Lake Street
2024-07-22
Price Target
$14
Loop Capital
$20
2024-04-15
Loop Capital
2024-04-15
Price Target
$20
Roth MKM
$16
2024-03-15
Roth MKM
2024-03-15
Price Target
$16
Loop Capital
—
2018-11-20
Loop Capital
2018-11-20
Price Target
—
Scenario prices are the last monthly forecast band of the current year. Probabilities are fixed model weights (25 / 50 / 25), not guarantees.
Equal-Weight S&P 500 Strategy Faces Challenges Amid Market Concentration

10-Year Treasury Yield Soars to Highest Level Since 2007

Bond Market Volatility Creates Income Opportunities

Value Investors Embrace Tech Stocks Amid AI Surge

Municipal Bonds Gain Appeal Amid Rising Interest Rates
American Vanguard Corporation is a diversified specialty and agriculture products company, which develops and markets products for crop protection and management, turf and ornamentals management, and public and animal health. It conducts its business through its operating subsidiaries, including AMVAC Chemical Corporation (AMVAC) for its domestic business and AMVAC Netherlands BV (AMVAC BV) for its international business. AMVAC is a manufacturer of chemical, biological and biorational products that develops and markets solutions for agricultural, commercial and consumer uses. It synthesizes and formulates chemicals and ferments and extracts microbial products for crops, turf, ornamental plants, and human and animal health protection. These products, which include insecticides, fungicides, and biorationals, are marketed in liquid, powder, and granular forms. AMVAC BV sells products both directly and through its network of subsidiaries in various international territories. It operates in the Industrials sector (AGRICULTURAL CHEMICALS industry).
American Vanguard Corp is not a good buy right now due to its declining performance and negative financial indicators. The current price is $1.60, which is down 58.01% year-to-date. The RSI is extremely low at 4.661, indicating oversold conditions, but this may not be a strong enough signal for a recovery. Additionally, the forward P/E ratio is 15.083, which is relatively high given the company's recent performance. The main risk is the significant decline in net income, which has been negative for multiple quarters, with the latest quarter showing a net income of -9,868,000 USD. Overall, the financial health and market sentiment do not favor a buy at this time.
4 analysts cover AVD: 3 rate it Buy, 1 Hold and 0 Sell.
No posts yet
Sign up or log in to join the discussionThis page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.